Subsequently, the overexpressed ALKBH5 demethylates ESPL1 mRNA and decreases the binding between ESPL1 mRNA and IGF2BP3, which facilitates the degradation of ESPL1 and ultimately inhibits the progression of BC (88). Here, ESPL1 is linked to breast cancer.